Skip to main content

Animations

MJFF Publications

3761 - 3770 of 8571 Results
Title
Year
  • Year
  • 2006
  • 2021
  • 2023
  • 2020
  • 2020
  • 2021
  • 2017
  • 2024
  • 2013
  • 2015
  • Summary Details
    RESTRICTED
    Title: Crossroads in GDNF therapy for Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.20861
    Best OA location URL:
    Citation Count: 173
  • Summary Details
    OPEN
    Title: Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participants
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100094
    Citation Count: 28
  • Summary Details
    OPEN
    Title: 0909 Pitolisant Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring
    Journal Name: SLEEP
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0909
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/58956
    Citation Count: 10
  • Summary Details
    OPEN
    Title: The Future of GDNF in Parkinson's Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2020.593572
    Citation Count: 41
  • Summary Details
    OPEN
    Title: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.17294/2330-0698.1836
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000004609
    Citation Count: 145
  • Summary Details
    OPEN
    Title: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03914-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Parkinson's Disease Biomarkers: Resources for Discovery and Validation
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2013.246
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results
    Journal Name: Journal of Translational Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12967-015-0704-9
    Citation Count: 89
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.